These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1141715)

  • 1. Vasoconstrictor activities of some novel synthetic steroids in alcoholic solution.
    Barry BW; Brace AR
    J Invest Dermatol; 1975 Jun; 64(6):418-22. PubMed ID: 1141715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible dosage regimens for topical steroids, assessed by vasoconstrictor assays using multiple applications.
    Woodford R; Haigh JM; Barry BW
    Dermatologica; 1983; 166(3):136-40. PubMed ID: 6852325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative bio-availability and activity of proprietary topical corticosteroid preparations: vasoconstrictor assays on thirty-one ointments.
    Barry BW; Woodford R
    Br J Dermatol; 1975 Nov; 93(5):563-71. PubMed ID: 1203181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paired comparison vasoconstrictor assays. A comparison of methods for the determination of relative vasoconstrictor potency of topically applied corticosteroids.
    Poulsen BJ; Burdick K; Bessler S
    Arch Dermatol; 1974 Mar; 109(3):367-71. PubMed ID: 4814938
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioavailability of topical steroids.
    Barry BW
    Dermatologica; 1976; 152 Suppl 1():47-65. PubMed ID: 955238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of diflucortolone valerate in the vasoconstriction tests].
    Wendt VH; Reckers R
    Arzneimittelforschung; 1976; 26(7b):1495-8. PubMed ID: 1036946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the vasoconstrictor activity of halopredone acetate in a modified McKenzie test.
    Rampini E; Rastelli A; Cardo P
    Eur J Clin Pharmacol; 1978 Dec; 14(5):325-9. PubMed ID: 729625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Skin vasoconstriction assay in the evaluation of topical corticosteroids in man. General problems and results obtained in a series of tests (author's transl)].
    Weirich EG; Lutz U
    Dermatologica; 1973; 147(6):353-75. PubMed ID: 4788215
    [No Abstract]   [Full Text] [Related]  

  • 9. Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoids.
    Schäfer-Korting M; Korting HC; Kerscher MJ; Lenhard S
    Clin Pharmacol Ther; 1993 Oct; 54(4):448-56. PubMed ID: 8222488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diflorasone diacetate: vasoconstrictor activity and clinical efficacy of a new topical corticosteroid.
    Bluefarb SM; Howard FM; Leibsohn E; Schlagel CA; Wexler L
    J Int Med Res; 1976; 4(6):454-61. PubMed ID: 800385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency ranking of two new topical corticosteroid creams containing 0.1% desonide or 0.05% halometasone utilising the human skin blanching assay.
    Meyer E; Smith EW; Haigh JM; Kanfer I
    Arzneimittelforschung; 1988 Dec; 38(12):1840-3. PubMed ID: 3245859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of the vasoconstrictive activity of preparations containing topical corticosteroids].
    Henschel V; Jaminet F
    J Pharm Belg; 1974; 29(1):3-15. PubMed ID: 4831715
    [No Abstract]   [Full Text] [Related]  

  • 13. [Systemic effect of diflucortolone valerate after dermal application (author's transl)].
    Wendt H; Reckers R
    Arzneimittelforschung; 1976; 26(7b):1509-13. PubMed ID: 188429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical 0.050% betamethasone dipropionate. Pharmacokinetic and pharmacodynamic dose-response studies in humans.
    Pershing LK; Lambert L; Wright ED; Shah VP; Williams RL
    Arch Dermatol; 1994 Jun; 130(6):740-7. PubMed ID: 8002644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of the vasoconstrictor assay and clinical activity in psoriasis.
    Woodford R
    Arch Dermatol; 1986 Dec; 122(12):1355. PubMed ID: 3789765
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of betamethasone dipropionate and salicylic acid in pharmaceutical preparations by high-performance liquid chromatography.
    Kedor-Hackmann ER; Gianotto EA; Santoro MI
    Drug Dev Ind Pharm; 1998 Jun; 24(6):553-5. PubMed ID: 9876622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plethysmographic recordings of skin pulses. VI. Further measurements of the vasoconstriction produced by corticosteroids.
    Thune P
    Acta Derm Venereol; 1972; 52(4):303-7. PubMed ID: 4115885
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of clobetasone butyrate and other topical steroids on skin thickness of the domestic pig.
    Winter GD; Wilson L
    Br J Dermatol; 1976 May; 94(5):545-50. PubMed ID: 1268065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of a novel corticosteroid formulation, fluocinonide in "FAPG" base, in the blanching test.
    Coldman MF; Lockerbie L; Laws EA
    Br J Dermatol; 1971 Dec; 85(6):573-6. PubMed ID: 4947552
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of glucocorticosteroids with enhanced ratio between topical and systemic effects.
    Thalén A; Brattsand R; Andersson PH
    Acta Derm Venereol Suppl (Stockh); 1989; 151():11-9; discussion 47-52. PubMed ID: 2624062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.